Maggie C.U. Cheang
0000-0001-5718-2501
Publication & Citation Trends
Publications
0 total
Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study OA
Cited by 5
Semantic Scholar
Abstract PD15-03: Overlapping molecular features (proliferation, immune signatures andTP53mutations) associated with palbociclib resistance inER+HER2- primary breast cancer
Cited by 0
Semantic Scholar
Abstract PD15-02: HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer
Cited by 1
Semantic Scholar
Abstract P5-06-14: A novel combination of a 2 gene score & TIL as a predictive Biomarker for responders to novel therapies in Indian TNBC - A population with greater proportion of TNBCs
Cited by 0
Semantic Scholar
Abstract PD15-06: Estrogen receptor expression thresholds by IHC and mRNA for Ki67 response to aromatase inhibition: A POETIC study
Cited by 0
Semantic Scholar
Use of mutation profiles to refine the classification of endometrial carcinomas OA
Cited by 296
Semantic Scholar
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2 OA
Cited by 195
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(160)
HER2/EGFR in Cancer Research
(96)
Cancer Immunotherapy and Biomarkers
(81)
Cancer Genomics and Diagnostics
(69)
Estrogen and related hormone effects
(67)
Affiliations
University of North Carolina at Chapel Hill
Roche (Switzerland)
Universitat Autònoma de Barcelona
University of London
Novartis (Switzerland)